Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Learn what to do in the last years before retirement to maximize your savings and prepare for a fulfilling retirement. Start planning now!
22,081 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
Pet owners are delaying routine vet visits to save money, yet expensive emergency surgeries keep pet-health firms in ...
NVIDIA leads AI chips while MICRON powers AI memory. This in-depth comparison helps investors decide the better buy: ...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
This article dives into Black Hills’ Q1 2026 earnings transcript, translating the numbers into actionable insights. L...
A new wave of fiber-infused sodas and gummies is hitting shelves as 'fibermaxxing' spurred a fiber push across snacks...
New Rochelle's zoning reform has sparked a housing surge, signaling a blueprint for faster development and safer lend...
A startup unveils a proprietary lithium extraction process that dramatically shortens timelines and boosts recovery, ...
A single quantum startup is quietly drawing the gaze of AI leaders and cloud giants alike. This article unpacks why i...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...